Regulatory aspects of the application of pharmacogenetics in drug discovery and development in Europe

Good Clinical Practice Journal

Volumn 7, Issue 6, 2000, Pages 11-13

  Knudsen, L E ^a   Renneberg, J ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME;

CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG METABOLISM; ENZYME ANALYSIS; EUROPE; GENETIC ANALYSIS; GENOME; GENOTYPE; HUMAN; INFORMED CONSENT; MEDICAL ETHICS; PATIENT MONITORING; PHARMACOGENETICS; SAFETY; SHORT SURVEY;

EID: 0033806483     PISSN: 13500961     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (3)

1. Use of pharmacogenetics in the drug development process
2. Etiske problemer ved genetiske undersogelser af DNA i projekt-blodprover
3. Pharmacogenetics and the practice of medicine